{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:13:57Z","timestamp":1793945637877,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2022AAC02034, 2023AAC03155, 2023AAC03207"],"award-info":[{"award-number":["2022AAC02034, 2023AAC03155, 2023AAC03207"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2022AAC02034, 2023AAC03155, 2023AAC03207"],"award-info":[{"award-number":["2022AAC02034, 2023AAC03155, 2023AAC03207"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070930, 82160497, 82360711"],"award-info":[{"award-number":["32070930, 82160497, 82360711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070930, 82160497, 82360711"],"award-info":[{"award-number":["32070930, 82160497, 82360711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Director Fund of Ningxia Key Laboratory of Craniocerebral Disease","award":["LNZR202304"],"award-info":[{"award-number":["LNZR202304"]}]},{"name":"Key R & D Plan Project of Ningxia Autonomous Region","award":["2020BFG02012"],"award-info":[{"award-number":["2020BFG02012"]}]},{"name":"Open subject of Ningxia Key Laboratory of Clinical Pathogenic Microbiology","award":["MKLG-2024-02"],"award-info":[{"award-number":["MKLG-2024-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03111-9","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T22:10:07Z","timestamp":1737151807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["M cells targeted H. pylori antigen SAM-FAdE displayed on bacterium-like particles induce protective immunity"],"prefix":"10.1186","volume":"23","author":[{"given":"Furui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"1","key":"3111_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, et al. Helicobacter pylori infection. Nat Reviews Disease Primers. 2023;9(1):19. https:\/\/doi.org\/10.1038\/s41572-023-00431-8.","journal-title":"Nat Reviews Disease Primers"},{"issue":"15","key":"3111_CR2","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1001\/jama.2017.1949","volume":"317","author":"RT Kavitt","year":"2017","unstructured":"Kavitt RT, Cifu AS. Management of Helicobacter pylori Infection. JAMA. 2017;317(15):1572\u20133. https:\/\/doi.org\/10.1001\/jama.2017.1949.","journal-title":"JAMA"},{"issue":"9","key":"3111_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","volume":"18","author":"E Tshibangu-Kabamba","year":"2021","unstructured":"Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Reviews Gastroenterol Hepatol. 2021;18(9):613\u201329. https:\/\/doi.org\/10.1038\/s41575-021-00449-x.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"3111_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s2468-1253(23)00354-0","volume":"9","author":"KA Fauzia","year":"2024","unstructured":"Fauzia KA, Tuan VP. Rising resistance: antibiotic choices for Helicobacter pylori infection. Lancet Gastroenterol Hepatol. 2024;9(1):7\u20138. https:\/\/doi.org\/10.1016\/s2468-1253(23)00354-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"3111_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s2352-4642(22)00026-8","volume":"6","author":"M Rowland","year":"2022","unstructured":"Rowland M. The continuing decline in the prevalence of Helicobacter pylori infection. Lancet Child Adolesc Health. 2022;6(3):139\u201340. https:\/\/doi.org\/10.1016\/s2352-4642(22)00026-8.","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"3111_CR6","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/s41423-021-00650-7","volume":"18","author":"J Yang","year":"2021","unstructured":"Yang J, Yan H. Mucosal epithelial cells: the initial sentinels and responders controlling and regulating immune responses to viral infections. Cell Mol Immunol. 2021;18(7):1628\u201330. https:\/\/doi.org\/10.1038\/s41423-021-00650-7.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"3111_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/intimm\/dxx064","volume":"29","author":"Y Date","year":"2017","unstructured":"Date Y, Ebisawa M, Fukuda S, et al. NALT M cells are important for immune induction for the common mucosal immune system. Int Immunol. 2017;29(10):471\u20138. https:\/\/doi.org\/10.1093\/intimm\/dxx064.","journal-title":"Int Immunol"},{"key":"3111_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3389\/fimmu.2019.01499","volume":"10","author":"A Dillon","year":"2019","unstructured":"Dillon A, Lo DDM, Cells. Intelligent Engineering of Mucosal Immune Surveillance. Front Immunol. 2019;10:1499. https:\/\/doi.org\/10.3389\/fimmu.2019.01499.","journal-title":"Front Immunol"},{"key":"3111_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41232-018-0072-y","volume":"38","author":"Y Nakamura","year":"2018","unstructured":"Nakamura Y, Kimura S, Hase K. M cell-dependent antigen uptake on follicle-associated epithelium for mucosal immune surveillance. Inflamm Regeneration. 2018;38:15. https:\/\/doi.org\/10.1186\/s41232-018-0072-y.","journal-title":"Inflamm Regeneration"},{"key":"3111_CR10","doi-asserted-by":"publisher","unstructured":"Vilander AC, Shelton K, LaVoy A, et al. Expression of E. Coli FimH enhances trafficking of an orally delivered Lactobacillus acidophilus vaccine to Immune Inductive sites via Antigen-presenting cells. Vaccines. 2023;11(7). https:\/\/doi.org\/10.3390\/vaccines11071162.","DOI":"10.3390\/vaccines11071162"},{"key":"3111_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2020.00015","volume":"11","author":"F Raya Tonetti","year":"2020","unstructured":"Raya Tonetti F, Arce L, Salva S, et al. Immunomodulatory properties of Bacterium-Like particles obtained from immunobiotic lactobacilli: prospects for their use as Mucosal adjuvants. Front Immunol. 2020;11:15. https:\/\/doi.org\/10.3389\/fimmu.2020.00015.","journal-title":"Front Immunol"},{"key":"3111_CR12","doi-asserted-by":"publisher","unstructured":"Sobia P, Archary D. Preventive HIV vaccines-leveraging on lessons from the past to pave the Way Forward. Vaccines. 2021;9(9). https:\/\/doi.org\/10.3390\/vaccines9091001.","DOI":"10.3390\/vaccines9091001"},{"key":"3111_CR13","doi-asserted-by":"publisher","unstructured":"Kasten-Jolly J, Lawrence DA. Cellular and Molecular Immunity to Influenza viruses and vaccines. Vaccines. 2024;12(4). https:\/\/doi.org\/10.3390\/vaccines12040389.","DOI":"10.3390\/vaccines12040389"},{"issue":"1","key":"3111_CR14","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1038\/s41598-022-07680-9","volume":"12","author":"P Chaikhumwang","year":"2022","unstructured":"Chaikhumwang P, Madapong A, Saeng-Chuto K, et al. Intranasal delivery of inactivated PRRSV loaded cationic nanoparticles coupled with enterotoxin subunit B induces PRRSV-specific immune responses in pigs. Sci Rep. 2022;12(1):3725. https:\/\/doi.org\/10.1038\/s41598-022-07680-9.","journal-title":"Sci Rep"},{"issue":"4","key":"3111_CR15","first-page":"163","volume":"9","author":"M Azizpour","year":"2017","unstructured":"Azizpour M, Hosseini SD, Jafari P, et al. Lactococcus lactis: a New Strategy for Vaccination. Avicenna J Med Biotechnol. 2017;9(4):163\u20138.","journal-title":"Avicenna J Med Biotechnol"},{"key":"3111_CR16","doi-asserted-by":"publisher","first-page":"1263586","DOI":"10.3389\/fimmu.2023.1263586","volume":"14","author":"X Zhou","year":"2023","unstructured":"Zhou X, Gao M, De X, et al. Bacterium-like particles derived from probiotics: progress, challenges and prospects. Front Immunol. 2023;14:1263586. https:\/\/doi.org\/10.3389\/fimmu.2023.1263586.","journal-title":"Front Immunol"},{"key":"3111_CR17","doi-asserted-by":"publisher","first-page":"1082273","DOI":"10.3389\/fimmu.2023.1082273","volume":"14","author":"H Sudo","year":"2023","unstructured":"Sudo H, Tokunoh N, Tsujii A, et al. The adjuvant effect of bacterium-like particles depends on the route of administration. Front Immunol. 2023;14:1082273. https:\/\/doi.org\/10.3389\/fimmu.2023.1082273.","journal-title":"Front Immunol"},{"issue":"4","key":"3111_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4062\/biomolther.2023.006","volume":"31","author":"HJ Ko","year":"2023","unstructured":"Ko HJ, Kim YJ. Antigen Delivery systems: Past, Present, and Future. Biomolecules Ther. 2023;31(4):370\u201387. https:\/\/doi.org\/10.4062\/biomolther.2023.006.","journal-title":"Biomolecules Ther"},{"key":"3111_CR19","doi-asserted-by":"publisher","first-page":"799942","DOI":"10.3389\/fmicb.2022.799942","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Yan F, Liu D, et al. Bacterium-like particles displaying the Rift Valley Fever Virus Gn Head protein induces efficacious Immune responses in immunized mice. Front Microbiol. 2022;13:799942. https:\/\/doi.org\/10.3389\/fmicb.2022.799942.","journal-title":"Front Microbiol"},{"issue":"24","key":"3111_CR20","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.vaccine.2019.04.078","volume":"37","author":"H Cheng","year":"2019","unstructured":"Cheng H, Chen J, Cai Z, et al. Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus. Vaccine. 2019;37(24):3205\u201313. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.078.","journal-title":"Vaccine"},{"issue":"2","key":"3111_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.13345\/j.cjb.160245","volume":"33","author":"L Hou","year":"2017","unstructured":"Hou L, Chen J, Qiao X, et al. [Design and immunogenicity evaluation for the bacteria-like particle vaccine against swine type O foot-and-mouth disease virus]. Sheng Wu gong Cheng xue bao\u2009=\u2009Chinese. J Biotechnol. 2017;33(2):217\u201327. https:\/\/doi.org\/10.13345\/j.cjb.160245.","journal-title":"J Biotechnol"},{"issue":"5328","key":"3111_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.277.5328.949","volume":"277","author":"S Kern\u00e9is","year":"1997","unstructured":"Kern\u00e9is S, Bogdanova A, Kraehenbuhl JP, et al. Conversion by Peyer\u2019s patch lymphocytes of human enterocytes into M cells that transport bacteria. Sci (New York NY). 1997;277(5328):949\u201352. https:\/\/doi.org\/10.1126\/science.277.5328.949.","journal-title":"Sci (New York NY)"},{"issue":"7","key":"3111_CR23","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nprot.2017.041","volume":"12","author":"A Beloqui","year":"2017","unstructured":"Beloqui A, Brayden DJ, Artursson P, et al. A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation. Nat Protoc. 2017;12(7):1387\u201399. https:\/\/doi.org\/10.1038\/nprot.2017.041.","journal-title":"Nat Protoc"},{"key":"3111_CR24","doi-asserted-by":"publisher","first-page":"1033201","DOI":"10.3389\/fmicb.2022.1033201","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang C, Zhang L, et al. Vitamin D(3) eradicates Helicobacter pylori by inducing VDR-CAMP signaling. Front Microbiol. 2022;13:1033201. https:\/\/doi.org\/10.3389\/fmicb.2022.1033201.","journal-title":"Front Microbiol"},{"key":"3111_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.intimp.2015.11.018","volume":"30","author":"J Liu","year":"2016","unstructured":"Liu J, Wang F, Luo H, et al. Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. Int Immunopharmacol. 2016;30:179\u201387. https:\/\/doi.org\/10.1016\/j.intimp.2015.11.018.","journal-title":"Int Immunopharmacol"},{"key":"3111_CR26","doi-asserted-by":"publisher","unstructured":"Guo L, Yin R, Xu G, et al. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils. Helicobacter. 2017;22(6). https:\/\/doi.org\/10.1111\/hel.12428.","DOI":"10.1111\/hel.12428"},{"key":"3111_CR27","doi-asserted-by":"publisher","unstructured":"Sun P, Kim Y, Lee H, et al. Carrot Pomace Polysaccharide (CPP) improves Influenza Vaccine Efficacy in Immunosuppressed mice via dendritic cell activation. Nutrients. 2020;12(9). https:\/\/doi.org\/10.3390\/nu12092740.","DOI":"10.3390\/nu12092740"},{"issue":"6","key":"3111_CR28","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","volume":"53","author":"K Lederer","year":"2020","unstructured":"Lederer K, Casta\u00f1o D, G\u00f3mez Atria D, et al. SARS-CoV-2 mRNA vaccines Foster Potent Antigen-Specific Germinal Center responses Associated with neutralizing antibody generation. Immunity. 2020;53(6):1281\u2013e12951285. https:\/\/doi.org\/10.1016\/j.immuni.2020.11.009.","journal-title":"Immunity"},{"key":"3111_CR29","doi-asserted-by":"publisher","unstructured":"Parsonnet J. Clinician-discoverers\u2013Marshall, Warren, and H. Pylori. N Engl J Med. 2005;353(23):2421\u20133. https:\/\/doi.org\/10.1056\/NEJMp058270.","DOI":"10.1056\/NEJMp058270"},{"issue":"4","key":"3111_CR30","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.gastro.2022.04.018","volume":"163","author":"Y Duan","year":"2022","unstructured":"Duan Y, Dou Y, Xu D. How can we better understand the gastric carcinogenesis of Helicobacter pylori? Gastroenterology. 2022;163(4):1121\u20132. https:\/\/doi.org\/10.1053\/j.gastro.2022.04.018.","journal-title":"Gastroenterology"},{"issue":"7","key":"3111_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrgastro.2017.57","volume":"14","author":"BN Dang","year":"2017","unstructured":"Dang BN, Graham DY. Helicobacter pylori infection and antibiotic resistance: a WHO high priority? Nat Reviews Gastroenterol Hepatol. 2017;14(7):383\u20134. https:\/\/doi.org\/10.1038\/nrgastro.2017.57.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"2","key":"3111_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/mi.2009.131","volume":"3","author":"K Ramirez","year":"2010","unstructured":"Ramirez K, Ditamo Y, Rodriguez L, et al. Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection. Mucosal Immunol. 2010;3(2):159\u201371. https:\/\/doi.org\/10.1038\/mi.2009.131.","journal-title":"Mucosal Immunol"},{"issue":"5","key":"3111_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/catal9050443","volume":"9","author":"ML Pham","year":"2019","unstructured":"Pham ML, Tran AM, Kittibunchakul S, et al. Immobilization of \u03b2-Galactosidases on the Lactobacillus cell surface using the peptidoglycan-binding motif LysM. Catalysts (Basel Switzerland). 2019;9(5):443. https:\/\/doi.org\/10.3390\/catal9050443.","journal-title":"Catalysts (Basel Switzerland)"},{"issue":"10","key":"3111_CR34","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1007\/s00253-014-5633-7","volume":"98","author":"GR Visweswaran","year":"2014","unstructured":"Visweswaran GR, Leenhouts K, van Roosmalen M, et al. Exploiting the peptidoglycan-binding motif, LysM, for medical and industrial applications. Appl Microbiol Biotechnol. 2014;98(10):4331\u201345. https:\/\/doi.org\/10.1007\/s00253-014-5633-7.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"Pt A","key":"3111_CR35","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ijbiomac.2021.10.135","volume":"193","author":"M Hu","year":"2021","unstructured":"Hu M, Wang F, Li N, et al. An antigen display system of GEM nanoparticles based on affinity peptide ligands. Int J Biol Macromol. 2021;193(Pt A):574\u201384. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.10.135.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"3111_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00253-012-4575-1","volume":"97","author":"P Ribelles","year":"2013","unstructured":"Ribelles P, Benbouziane B, Langella P, et al. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface. Appl Microbiol Biotechnol. 2013;97(3):1231\u20139. https:\/\/doi.org\/10.1007\/s00253-012-4575-1.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"3111_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/jam.14346","volume":"127","author":"XW Qiao","year":"2019","unstructured":"Qiao XW, Yu XM, Li PC, et al. Immune efficacy of a porcine circovirus type 2 vaccine purified using Gram-positive enhancer matrix surface display technology. J Appl Microbiol. 2019;127(3):658\u201369. https:\/\/doi.org\/10.1111\/jam.14346.","journal-title":"J Appl Microbiol"},{"issue":"4","key":"3111_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/08820139.2018.1439505","volume":"47","author":"D Wang","year":"2018","unstructured":"Wang D, Lu J, Yu J, et al. A novel PspA protein vaccine Intranasal Delivered by Bacterium-Like particles provides Broad Protection against Pneumococcal Pneumonia in mice. Immunol Investig. 2018;47(4):403\u201315. https:\/\/doi.org\/10.1080\/08820139.2018.1439505.","journal-title":"Immunol Investig"},{"key":"3111_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2020.03.002","volume":"222","author":"J Bi","year":"2020","unstructured":"Bi J, Li F, Zhang M, et al. An HIV-1 vaccine based on bacterium-like particles elicits Env-specific mucosal immune responses. Immunol Lett. 2020;222:29\u201339. https:\/\/doi.org\/10.1016\/j.imlet.2020.03.002.","journal-title":"Immunol Lett"},{"issue":"32","key":"3111_CR40","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1016\/j.vaccine.2012.04.032","volume":"30","author":"A de Haan","year":"2012","unstructured":"de Haan A, Haijema BJ, Voorn P, et al. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. Vaccine. 2012;30(32):4884\u201391. https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.032.","journal-title":"Vaccine"},{"issue":"9","key":"3111_CR41","doi-asserted-by":"publisher","first-page":"e73365","DOI":"10.1371\/journal.pone.0073365","volume":"8","author":"A Carbo","year":"2013","unstructured":"Carbo A, Bassaganya-Riera J, Pedragosa M, et al. Predictive computational modeling of the mucosal immune responses during Helicobacter pylori infection. PLoS ONE. 2013;8(9):e73365. https:\/\/doi.org\/10.1371\/journal.pone.0073365.","journal-title":"PLoS ONE"},{"key":"3111_CR42","doi-asserted-by":"publisher","first-page":"575271","DOI":"10.3389\/fcimb.2020.575271","volume":"10","author":"J Xie","year":"2020","unstructured":"Xie J, Wen J, Chen C, et al. Notch 1 is involved in CD4(+) T cell differentiation into Th1 subtype during Helicobacter pylori infection. Front Cell Infect Microbiol. 2020;10:575271. https:\/\/doi.org\/10.3389\/fcimb.2020.575271.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"3111_CR43","doi-asserted-by":"publisher","first-page":"e24697","DOI":"10.5812\/jjm.24697","volume":"8","author":"H Ghasemian Safaei","year":"2015","unstructured":"Ghasemian Safaei H, Faghri J, Moghim S, et al. Production of IFN-\u03b3 and IL-4 against Intact Catalase and Constructed Catalase Epitopes of Helicobacter pylori from T-Cells. Jundishapur J Microbiol. 2015;8(12):e24697. https:\/\/doi.org\/10.5812\/jjm.24697.","journal-title":"Jundishapur J Microbiol"},{"issue":"2","key":"3111_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/iai.00524-09","volume":"78","author":"W Khamri","year":"2010","unstructured":"Khamri W, Walker MM, Clark P, et al. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4\u2009+\u2009T lymphocytes. Infect Immun. 2010;78(2):845\u201353. https:\/\/doi.org\/10.1128\/iai.00524-09.","journal-title":"Infect Immun"},{"issue":"3","key":"3111_CR45","doi-asserted-by":"publisher","first-page":"e2350662","DOI":"10.1002\/eji.202350662","volume":"54","author":"Y Guo","year":"2024","unstructured":"Guo Y, Chen J, Huang Y, et al. Increased infiltration of CD4(+) IL-17A(+) FOXP3(+) T cells in Helicobacter pylori-induced gastritis. Eur J Immunol. 2024;54(3):e2350662. https:\/\/doi.org\/10.1002\/eji.202350662.","journal-title":"Eur J Immunol"},{"key":"3111_CR46","doi-asserted-by":"publisher","first-page":"974698","DOI":"10.3389\/fvets.2022.974698","volume":"9","author":"AMI Abuzeid","year":"2022","unstructured":"Abuzeid AMI, Hefni MM, Huang Y, et al. Immune pathogenesis in pigeons during experimental Prohemistomum vivax infection. Front Veterinary Sci. 2022;9:974698. https:\/\/doi.org\/10.3389\/fvets.2022.974698.","journal-title":"Front Veterinary Sci"},{"issue":"1","key":"3111_CR47","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1038\/s41598-018-21120-7","volume":"8","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Nagatake T, Nasu A, et al. Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice. Sci Rep. 2018;8(1):2904. https:\/\/doi.org\/10.1038\/s41598-018-21120-7.","journal-title":"Sci Rep"},{"issue":"2","key":"3111_CR48","doi-asserted-by":"publisher","first-page":"e1004624","DOI":"10.1371\/journal.ppat.1004624","volume":"11","author":"MD Zabel","year":"2015","unstructured":"Zabel MD, Avery AC. Prions\u2013not your immunologist\u2019s pathogen. PLoS Pathog. 2015;11(2):e1004624. https:\/\/doi.org\/10.1371\/journal.ppat.1004624.","journal-title":"PLoS Pathog"},{"issue":"8","key":"3111_CR49","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Lu Y, Qi J, et al. An update on oral drug delivery via intestinal lymphatic transport. Acta Pharm Sinica B. 2021;11(8):2449\u201368. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.022.","journal-title":"Acta Pharm Sinica B"},{"issue":"1\u20132","key":"3111_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ijpharm.2018.05.003","volume":"545","author":"MJ Uddin","year":"2018","unstructured":"Uddin MJ, Gill HS. From allergen to oral vaccine carrier: a new face of ragweed pollen. Int J Pharm. 2018;545(1\u20132):286\u201394. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.05.003.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"3111_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijpharm.2014.06.052","volume":"473","author":"T Ma","year":"2014","unstructured":"Ma T, Wang L, Yang T, et al. M-cell targeted polymeric lipid nanoparticles containing a toll-like receptor agonist to boost oral immunity. Int J Pharm. 2014;473(1\u20132):296\u2013303. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.052.","journal-title":"Int J Pharm"},{"issue":"9","key":"3111_CR52","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1128\/iai.70.9.5096-5106.2002","volume":"70","author":"P Londo\u00f1o-Arcila","year":"2002","unstructured":"Londo\u00f1o-Arcila P, Freeman D, Kleanthous H, et al. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun. 2002;70(9):5096\u2013106. https:\/\/doi.org\/10.1128\/iai.70.9.5096-5106.2002.","journal-title":"Infect Immun"},{"issue":"1","key":"3111_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.vaccine.2005.11.020","volume":"25","author":"MI Husseiny","year":"2007","unstructured":"Husseiny MI, Wartha F, Hensel M. Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2. Vaccine. 2007;25(1):185\u201393. https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.020.","journal-title":"Vaccine"},{"issue":"4","key":"3111_CR54","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1128\/iai.01242-06","volume":"75","author":"MG Stokes","year":"2007","unstructured":"Stokes MG, Titball RW, Neeson BN, et al. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. Anthracis. Infect Immun. 2007;75(4):1827\u201334. https:\/\/doi.org\/10.1128\/iai.01242-06.","journal-title":"Infect Immun"},{"issue":"2","key":"3111_CR55","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1128\/iai.05525-11","volume":"80","author":"MD Ju\u00e1rez-Rodr\u00edguez","year":"2012","unstructured":"Ju\u00e1rez-Rodr\u00edguez MD, Arteaga-Cort\u00e9s LT, Kader R, et al. Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system. Infect Immun. 2012;80(2):798\u2013814. https:\/\/doi.org\/10.1128\/iai.05525-11.","journal-title":"Infect Immun"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03111-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T22:10:18Z","timestamp":1737151818000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03111-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3111"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03111-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Experimentation Ethics Committee of Ningxia Medical University (IACUU number: NYLAC-2022-169).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approve the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}